Use this URL to cite or link to this record in EThOS:
Title: The role of microvascular tumour endothelium in the recruitment of CD8+ T lymphocytes in colorectal cancer
Author: Hepburn, Elizabeth Amanda
ISNI:       0000 0004 6346 7652
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2017
Availability of Full Text:
Access from EThOS:
Access from Institution:
Tumour endothelial cells (TEC) display a distinct and angiogenic phenotype. They also permit trafficking of anti-tumour CD8+ T-lymphocytes into tumour stroma. I aimed to develop and validate an isolation technique and in vitro model of primary human colorectal TEC, characterize the TEC phenotype, and investigate intratumoural micro-environmental signals regulating CD8+ T-cell recruitment by TEC. Flow cytometry, ELISA and QPCR revealed CD31, VWF, CD105, VEGFR’s, VE-Cadherin, CD13 and tumour specific marker TEM8 expression by colorectal TEC. TEC and tumour associated fibroblast (TAFB) produced higher concentrations of IL-6 and CCL2/MCP-1. Static and flow-based assays, demonstrated increased CD8+ T-cell adhesion by TEC and adhesion was augmented after conditioning with CRC derived TAFB supernatant. IL-6 and CCL2/MCP-1 blockade supressed CD8 T-cell adhesion. Endothelin-1 (ET1) was produced by TAFB and Endothelin Receptor B (ETB) was preferentially expressed by CRC endothelium, blockade of which, resulted in significantly increased ICAM-1 expression and CD8+ T-cell adhesion to TEC. My validated in vitro TEC model confirms that CRC TEC has a unique phenotype influenced by the tumour microenvironment and that ETB inhibition may facilitate increased recruitment of CD8+ T-lymphocytes into the tumour stroma. This commands further investigation with the aim of developing an anti-cancer therapy in CRC.
Supervisor: Not available Sponsor: Cancer Research UK
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: QH301 Biology ; RC0254 Neoplasms. Tumors. Oncology (including Cancer)